Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm

Detalles Bibliográficos
Autor principal: Mossad, Sherif Beniameen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800127/
https://www.ncbi.nlm.nih.gov/pubmed/33998136
http://dx.doi.org/10.1111/ajt.16687
_version_ 1784861225405906944
author Mossad, Sherif Beniameen
author_facet Mossad, Sherif Beniameen
author_sort Mossad, Sherif Beniameen
collection PubMed
description
format Online
Article
Text
id pubmed-9800127
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-98001272022-12-30 Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm Mossad, Sherif Beniameen Am J Transplant Letter to the Editor American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2021-08 2022-12-30 /pmc/articles/PMC9800127/ /pubmed/33998136 http://dx.doi.org/10.1111/ajt.16687 Text en Copyright © 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Mossad, Sherif Beniameen
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm
title Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm
title_full Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm
title_fullStr Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm
title_full_unstemmed Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm
title_short Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm
title_sort reduced humoral response to mrna sars-cov-2 bnt162b2 vaccine in kidney transplant recipients without prior exposure to the virus: no cause for alarm
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800127/
https://www.ncbi.nlm.nih.gov/pubmed/33998136
http://dx.doi.org/10.1111/ajt.16687
work_keys_str_mv AT mossadsherifbeniameen reducedhumoralresponsetomrnasarscov2bnt162b2vaccineinkidneytransplantrecipientswithoutpriorexposuretothevirusnocauseforalarm

Ejemplares similares